Patient-Specific Access For Locally Unlicenced Therapies
When a therapy is approved somewhere in the world but not marketed locally, treatment plans face a gap. Individual Import closes that gap by converting external approvals into named-patient access.
Individual Import is the bridge between global innovation and local care. In settings where suitable local options are absent, approved therapies from other regions become additional choices for individual patients.
When a medicine exists but isn’t available locally, Individual Import enables compliant, patient-specific access so treatment can proceed without waiting for commercialization.
About Individual Import
A true extension of therapeutic choice, Individual import creates another chance for the patient.
Access to global innovation
Case-by-case access to therapies approved in other regions when local options are absent or unsuitable.Clinically governed, patient-first
Access grounded in medical need and aligned with hospital committees for transparent, defensible decisions.Transparent cost & procurement fit
Upfront quotes compatible with hospital purchasing and budget workflows.Supply Optimization
Optimization for accelerated lead time on routinely imported products.
Our Named Patient Import Services
Why Komtur?

Patient-First, Care-Centric Handling
Single case owner, transparent status, and checklist documentation help keep cases moving and care continuous.

Speed with Certainty
Bonded-warehouse release, established customs and Importer of Record (IOR) workflows, and temperature-controlled last-mile delivery to hospital or pharmacy receipt.

Licensed Global Access Network
Quality-assured sourcing with falsified-medicines safeguards, serialization, and end-to-end batch traceability.

Authority-Aligned, Multi-Country Enablement
Correct use of named-patient and shortage pathways, plus practical broker and IOR guidance as well as documentation support.

Proactive Access Insights
Continuous shortage and regulatory-approval monitoring, demand validation, and early qualification of alternatives to protect continuity of care.